AMAG Pharmaceuticals (AMAG) Posts Narrower than Expected Q2 Loss
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Financial Fact:
Basic (in shares): 34.17M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Basic (in shares): 34.17M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
AMAG Pharmaceuticals (NASDAQ: AMAG) reported Q2 loss of ($0.92), $0.14 better than the analyst estimate of ($1.06). Revenue for the quarter came in at $15.4 million versus the consensus estimate of $14.8 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Innovaro (INV) Misses Q2 EPS by 9c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
